Showing results (221-230 of 267) with videos related to
Sort By:
Pageof 27
The Journal of Infection|July 6, 2010
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65RC Stephan, B Dauer, M Bickel, et al.European Journal of Medical Research|April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patientsH Knechten, C Stephan, F A Mosthaf, et al.British Journal of Cancer|September 11, 2008
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnosticsG Kristiansen, F R Fritzsche, K Wassermann, et al.Medical Microbiology and Immunology|August 24, 2014
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysisT Wolf, B Fuß, P Khaykin, et al.Journal of Biomolecular Screening|February 24, 2012
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasisZhiyong Ding, Peter German, Shanshan Bai, et al.British Journal of Cancer|January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomyW Weichert, A Röske, V Gekeler, et al.International Journal of Cancer|July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?K Jung, C Stephan, U Elgeti, et al.Journal of Biomolecular Screening|February 15, 2014
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer TherapyNenggang Zhang, Kathleen Scorsone, Gouqing Ge, et al.HIV Medicine|September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophyM Bickel, J Eisen, C Stephan, et al.HIV Medicine|July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 yearsI Krznaric, M Bickel, A Carganico, et al.Pageof 27